Patent · US Active

Compounds for treatment of senescence-related disorders

US11014949B2 · kind B2 · utility

1Cited by
1References
10Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 15, 2017
Grant dateMay 25, 2021
Priority date
Expiry dateNov 15, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F9/5456
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds of general formula (I) in particular for use in the treatment of senescence-related diseases, such as idiopathic pulmonary fibrosis, sarcopenia, diabetes, obesity, osteoarthritis, chronic inflammations, glaucoma, cataracts, radiation-induced oral mucosis, renal transplantation, prostatic hyperplasia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.